LHRHa aided liposomes targeting to human ovarian tumor cells: Preparation and cellular uptake

Pharmazie

Volumn 63, Issue 6, 2008, Pages 434-438

  Yuan, Wen Min ^a   Song, Qin Guo ^a   Zhang, Zhi Rong ^a   Fu, Yao ^a   Liu, Ji ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DOCETAXEL; FLUORESCEIN; GONADORELIN DERIVATIVE; LIPOSOME; MONOCHOLESTEROL SUCCINATE; SUCCINIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG UPTAKE; ENCAPSULATION; HELA CELL; HUMAN; HUMAN CELL; OVARY TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHOLESTEROL ESTERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FEMALE; FLUORESCEIN; FLUORESCENCE; HUMANS; LIPOSOMES; LUTEINIZING HORMONE; MAGNETIC RESONANCE SPECTROSCOPY; OVARIAN NEOPLASMS; REFERENCE STANDARDS; REGRESSION ANALYSIS; TAXOIDS;

EID: 46849092597     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7419     Document Type: Article

References (11)

1. Benaki DC, Paxinou E, Magafa V, Pairas GN, Manessi-Zoupa E, Cordopatis PA, Mikros E (2001) Conformational analysis of the nonapeptide leuprorelin using NMR and molecular modeling. Int J Pept Res Ther 8: 77-87.
2. Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T (2003) Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release 91: 61-73.
3. Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L (2003) Preparation, characterization, cytotoxicity and pharmacokinetics of lipo-somes containing docetaxel. J Control Release 91: 417-429.
4. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 120: 18-26.
5. Markman M, Kennedy A, Webster K (2001) Combination chemo-therapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum. J Clin Oncol 19: 1901-1905.
6. Miyazaki M, Schally AV, Nagy A, Lamharzi N, Halmos G, Szepeshazi K, Armatis P (1999) Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice. Am J Obstet Gynecol 180: 1095-1103.
7. Tros de Ilarduya C, Düzgünes N (2000) Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochem Biophys Acta 1463: 333-342.
8. Tros de Ilarduya C, Arangoa MA, Moreno-Aliaga MJ, Duzgunes N (2002) Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes. Biochem Biophys Acta 1561: 209-221.
9. Völker P, Gründker C, Schmidt O, Schulz KD, Emons G (2002) Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. Am J Obstet Gynecol 186: 171-179.
10. Wu CC, Li LY, Zhang D, Song H (2005) Research on synthesis of monocho-lesterylsuccinate, J Tianjing Polytechnic Univ 24: 27-33 (in Chinese).
11. Xu XL, Fu Y, Hu HY, Duan YR, Zhang ZR (2006) Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography. J Pharm Biomed Anal 41: 266-273.